Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Lifecore Biomedical, Inc. (LFCR) had Debt to Equity Ratio of 4.75 for the most recently reported fiscal quarter, ending 2023-05-31.
| Income Statement Financials | |
$-6.49M |
|
$-35.57M |
|
$-15.13M |
|
$8.65M |
|
$-9.80M |
|
$3.31M |
|
$-28.06M |
|
$-24.75M |
|
$-24.75M |
|
$-24.98M |
|
$-24.98M |
|
$-35.57M |
|
$-24.98M |
|
$3.31M |
|
$7.21M |
|
29.96M |
|
29.96M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$93.88M |
|
$134.39M |
|
$159.67M |
|
$253.54M |
|
$39.29M |
|
$165.97M |
|
$179.17M |
|
$218.46M |
|
$-4.23M |
|
$17.01M |
|
$35.09M |
|
30.32M |
|
| Cash Flow Statement Financials | |
$-17.44M |
|
$-4.81M |
|
$39.70M |
|
$1.64M |
|
$19.09M |
|
$17.45M |
|
$3.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
0.83 |
|
|
Debt to Equity Ratio |
4.75 |
-133.28% |
|
-51.06% |
|
-51.06% |
|
-- |
|
381.40% |
|
548.26% |
|
$-38.92M |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
-0.37 |
|
-0.22 |
|
-402.61 |
|
590.43% |
|
-146.85% |
|
-9.85% |
|
-12.42% |
|
$1.16 |
|
$-1.30 |
|
$-0.58 |
|